| Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer O Saatci, A Kaymak, U Raza, PG Ersan, O Akbulut, CE Banister, ... Nature communications 11 (1), 2416, 2020 | 276 | 2020 |
| A highly potent TACC3 inhibitor as a novel anticancer drug candidate O Akbulut, D Lengerli, O Saatci, E Duman, UOS Seker, A Isik, A Akyol, ... Molecular cancer therapeutics 19 (6), 1243-1254, 2020 | 28 | 2020 |
| An immunohistochemical approach to detect oncogenic CTNNB1 mutations in primary neoplastic tissues A Akyol, G Güner, HS Özşeker, A Işık, Ö Atcı, S Uzun, E Atayar, F Ozaltin, ... Laboratory Investigation 99 (1), 128-137, 2019 | 22 | 2019 |
| Class III β-tubulin expression in colorectal neoplasms is a potential predictive biomarker for paclitaxel response S Öztop, A Işik, G Güner, H Gürdal, E Karabulut, E Yilmaz, A Akyol Anticancer Research 39 (2), 655-662, 2019 | 21 | 2019 |
| Prognostic and predictive value of tumor infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer SC Efil, G Guner, DC Guven, B Celikten, E Celebiyev, H Taban, A Akyol, ... Clinics and Research in Hepatology and Gastroenterology 47 (7), 102171, 2023 | 10 | 2023 |
| Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer O Saatci, R Alam, KT Huynh-Dam, A Isik, M Uner, N Belder, PG Ersan, ... Cell Death & Disease 15 (6), 418, 2024 | 9 | 2024 |
| Loss of CTNNB1 exon 3 in sclerosing angiomatoid nodular transformation of the spleen S Uzun, Ö Özcan, A Işık, A Sağlam, G Gedikoğlu, AS Demiröz, I Kuzu, ... Virchows Archiv, 1-8, 2021 | 8 | 2021 |
| Gastric Carcinoma with Lymphoid Stroma: A Combination of Mismatch Repair Deficient Medullary Type and Epstein–Barr Virus-associated Gastric Carcinomas M Uner, A Isık, S Oztop, E Karabulut, S Demirkol-Canlı, A Akyol International Journal of Surgical Pathology 30 (6), 623-633, 2022 | 7 | 2022 |
| Morphologic and immunohistochemical appraisal of primary gastric carcinomas G Guner, A Isik, E Karabulut, G Gedikoglu, C Sokmensuer, A Akyol Applied Immunohistochemistry & Molecular Morphology 26 (10), e107-e115, 2018 | 6 | 2018 |
| Effect of paclitaxel loaded chitosan nanoparticles and quantum dots on breast cancer GM Demir, M Ilhan, EK Akkol, H Taştan, A Işık, İT Değim Proceedings 1 (10), 1074, 2017 | 5 | 2017 |
| Late Palaeozoic evolution of the Kuhtahya–Bolkardag Belt A Ozcan, MC Göncüoglu, N Turan, D Uysal, K Sentürk, A Isik Middle East Technical University (METU) Journal of Pure and Applied Science …, 1988 | 5 | 1988 |
| Role of reduced Bdnf expression in novel Apc mutant allele-induced intestinal and colonic tumorigenesis in mice A Gok, A Işik, S Bakir, S Uzun, G Guner, O Ozcan, B Cerci, I Onbaşilar, ... in vivo 37 (4), 1562-1575, 2023 | 3 | 2023 |
| The prognostic and predictive role of class III β-Tubulin and hENT1 expression in patients with advanced pancreatic ductal adenocarcinoma TK Sahin, A Isik, DC Guven, F Ceylan, B Babaoglu, A Akyol, S Yalcin, ... Pancreatology 24 (2), 279-288, 2024 | 2 | 2024 |
| A novel gene list identifies tumors with a stromal-mesenchymal phenotype and worse prognosis in gastric cancer S Demirkol Canli, M Uner, B Kucukkaraduman, DA Karaoglu, A Isik, ... Cancers 15 (11), 3035, 2023 | 2 | 2023 |
| 456P Prognostic and predictive value of tumor-infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer SC Efil, G Güner, DC Guven, B Çelikten, E Çelebiyev, H Taban, A Akyol, ... Annals of Oncology 32, S561, 2021 | 2 | 2021 |
| Claudin 18.2 expression in gastric adenocarcinomas in a large Turkish cohort A Işık, G Güner, C Zeyneloğlu, SD Canlı, H Tastan, A Akyol Abant Medical Journal 12 (2), 122-130, 2023 | 1 | 2023 |
| A new CRISPR‐mediated Apc knockout allele leads to pyloric gland adenoma‐like gastric polyps in mice with C57BL/6;FVB/N mixed background S Uzun, Ö Özcan, A Gök, A Işık, S Bakır, A Günel‐Özcan, İ Onbaşılar, ... Animal Models and Experimental Medicine, 2025 | | 2025 |
| Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER plus breast cancer Ö Saatçi, R Alam, KT Huynh-Dam, A Işık, M Üner, N Belder, PG Ersan, ... Nature Publishing Group, 2024 | | 2024 |
| 1638P The prognostic and predictive role of class III β-tubulin and hENT1 expression in patients with advanced pancreatic ductal adenocarcinoma TK Sahin, A Isik, DC Guven, F Ceylan, B Babaoglu, A Akyol, S Yalcin, ... Annals of Oncology 34, S906, 2023 | | 2023 |
| Characterization of the Subcellular Distribution of Phospho-β-catenin in Colorectal Cancer S Uzun, A Isik, K Katipoglu, G Guner, A Akyol in vivo 37 (4), 1576-1583, 2023 | | 2023 |
Aytekin AkyolProfessor of Pathology, Hacettepe UniversityVerified email at hacettepe.edu.tr
